WASHINGTON — The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback